Q3 2023 ProKidney Corp Earnings Call TranscriptNov 14, 2023$1.52 (-5.00%)Earnings- ProKidney Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- ProKidney Corp at Jefferies Healthcare Conference TranscriptJun 08, 2023
- ProKidney Corp at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
ProKidney Corp at Jefferies Healthcare Conference Transcript
(inaudible) everyone. Thank you for attending Jefferies' New York Healthcare Conference. My name is Kelly Shi, one of the Biotech Analyst here. And please join me to welcome, Dr. Tim Bertram, Chief Executive Officer of ProKidney for this fireside chat session. And then we're going to talk about the novel cell therapy and with the big potential for treating CKD space. And welcome, Tim.
Questions & Answers
Maybe first, you can talk about the company overview to the audience who are not so familiar with your story.
Yeah, thank you, Kelly, and thank you all of you for -- to hear our story. ProKidney is an autologous homologous cell therapy company with a mission and goal to end kidney failure. This is important on a number of levels because part of our mission and goal also is to drive down cost for both the patient and the healthcare system.
We're in Phase 3 clinical stage pharmaceutical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
